Works Cited

1. Drachman DA, Hart CW. An approach to the dizzy patient. Neurology. 1972;22(4):323-334.

2. Goh LG. Dizziness update: a new approach and treatment based on timing and triggers. Arch Gen Intern Med. 2018;2(2):17-22.

3. Edlow JA. Diagnosing dizziness: we are teaching the wrong paradigm! Acad Emerg Med. 2013;20(10):1064-1066.

4. Ammar H, Govindu R, Fouda R, Zohdy W, Supsupine E. Dizziness in a community hospital: central neurological causes, clinical predictors, and diagnostic yield and cost of neuroimaging studies. J Community Hosp Intern Med Perspect. 2017;7(2):73-78.

5. Newman-Toker DE, Cannon LM, Stofferahn ME, Rothman RE, Hsieh YH, Zee DS. Imprecision in patient reports of dizziness symptom quality: a cross-sectional study conducted in an acute care setting. Mayo Clin Proc. 2007;82(11):1329-1340.

6. Stanton VA, Hsieh YH, Camargo CA Jr, et al. Overreliance on symptom quality in diagnosing dizziness: results of a multicenter survey of emergency physicians. Mayo Clin Proc. 2007;82(11):1319-1328.

7. Muncie HL, Sirmans SM, James E. Dizziness: approach to evaluation and management. Am Fam Physician. 2017;95(3):154-162.

8. Edlow JA, Gurley KL, Newman-Toker DE. A new diagnostic approach to the adult patient with acute dizziness. J Emerg Med. 2018;54(4):469-483.

9. Palmeri R. Benign Paroxysmal Positional Vertigo (BPPV). Available at http://knowledge.statpearls.com/chapter/0/38044. Last accessed September 12, 2018.

10. Edlow JA. Diagnosing patients with acute-onset persistent dizziness. Ann Emerg Med. 2018;71(5):625-631.

12. Rughani AI. Brain Anatomy. Available at https://emedicine.medscape.com/article/1898830-overview. Last accessed September 12, 2018.

13. Lee C, Jones TA. Neuropharmacological targets for drug action in vestibular sensory pathways. J Audiol Otol. 2017;21(3):125-132.

14. Cronin T, Arshad Q, Seemungal BM. Vestibular deficits in neurodegenerative disorders: balance, dizziness, and spatial disorientation. Front Neurol. 2017;8:538.

15. Fife TD. Dizziness in the outpatient care setting. Continuum (Minneap Minn). 2017;23(2):359-395.

16. Merfeld DM, Priesol A, Lee D, Lewis RF. Potential solutions to several vestibular challenges facing clinicians. J Vestib Res. 2010;20(1):71-77.

17. Shupert CL. Vestibular Neuritis and Labyrinthitis. Available at https://vestibular.org/labyrinthitis-and-vestibular-neuritis. Last accessed September 12, 2018.

18. Baumgartner B. Peripheral Vertigo. Available at https://www.statpearls.com/kb/viewarticle/27021. Last accessed September 12, 2018.

19. Beh SC. Top 5 CNS Causes of Dizziness. Available at http://www.neurologytimes.com/headache-and-migraine/top-5-cns-causes-dizziness. Last accessed September 12, 2018.

20. Stanton M. Vertigo. Available at http://knowledge.statpearls.com/chapter/0/31130. Last accessed September 12, 2018.

21. Pérez-Vázquez P, Franco-Gutiérrez V. Treatment of benign paroxysmal positional vertigo: a clinical review. J Otol. 2017;12(4):165-173.

22. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017;156(3 Suppl):S1-S47.

23. Shepard NT. Signs and Symptoms of Central Vestibular Disorders. Available at https://www.asha.org/Articles/Signs-and-Symptoms-of-Central-Vestibular-Disorders. Last accessed September 12, 2018.

24. Woodhouse S. Benign Paroxysmal Positional Vertigo (BPPV). Available at https://vestibular.org/understanding-vestibular-disorders/types-vestibular-disorders/benign-paroxysmal-positional-vertigo. Last accessed September 12, 2018.

25. Kollén L, Frändin K, Möller M, Fagevik Olsén M, Möller C. Benign paroxysmal positional vertigo is a common cause of dizziness and unsteadiness in a large population of 75-year-olds. Aging Clin Exp Res. 2012;24(4):317-323.

26. Kerrigan MA, Costigan MF, Blatt KJ, Mathiason MA, Domroese ME. Prevalence of benign paroxysmal positional vertigo in the young adult population. Phys Med Rehab. 2013;5(9):778-785.

27. Ekvall Hansson E, Månsson NO, Håkansson A. Benign paroxysmal positional vertigo among elderly patients in primary health care. Gerontology. 2005;51(6):386-389.

28. von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78(7):710-715.

29. Shaia WT. Dizziness Evaluation: Overview, Technique, Pathology and Treatment. Available at https://emedicine.medscape.com/article/1831429-overview. Last accessed September 12, 2018.

30. Talmud JD. Dix Hallpike Maneuver. Available at http://knowledge.statpearls.com/chapter/0/20632. Last accessed September 12, 2018.

31. D'Silva LJ, Whitney SL, Santos M, Dai H, Kluding PM. The impact of diabetes on mobility, balance, and recovery after repositioning maneuvers in individuals with benign paroxysmal positional vertigo. J Diabetes Complications. 2017;31(6):976-982.

32. von Brevern M, Bertholon P, Brandt T, et al. Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res. 2015;25(3-4):105-117.

33. House MG, Honrubia V. Theoretical models for the mechanisms of benign paroxysmal positional vertigo. Audiol Neurootol. 2003;8(2):91-99.

34. Messina A, Casani AP, Manfrin M, Guidetti G. Italian survey on benign paroxysmal positional vertigo. Acta Otorhinolaryngol Ital. 2017;37(4):328-335.

35. Jeong SH, Kim HJ, Kim JS. Vestibular neuritis. Semin Neurol. 2013;33(3):185-194.

36. Boston ME. Labyrinthitis. Available at https://emedicine.medscape.com/article/856215-overview. Last accessed September 12, 2018.

37. Newman-Toker DE, Edlow JA. TiTrATE: a novel, evidence-based approach to diagnosing acute dizziness and vertigo. Neurol Clin. 2015;33(3):577-599.

38. Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Ménière's disease. J Vestib Res. 2015;25(1):1-7.

39. Li JC. Meniere Disease (Idiopathic Endolymphatic Hydrops). Available at https://emedicine.medscape.com/article/1159069-overview. Last accessed September 12, 2018.

40. Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int. 2013;110(29-30):505-515.

41. Strupp M, Kim JS, Murofushi T, et al. Bilateral vestibulopathy: diagnostic criteria consensus document of the Classification Committee of the Bárány Society. J Vestib Res. 2017;27(4):177-189.

42. Ward BK, Agrawal Y, Hoffman HJ, Carey JP, Della Santina CC. Prevalence and impact of bilateral vestibular hypofunction: results from the 2008 US National Health Interview Survey. JAMA Otolaryngol Head Neck Surg. 2013;139(8):803-810.

43. Lucieer F, Vonk P, Guinand N, Stokroos R, Kingma H, van de Berg R. Bilateral vestibular hypofunction: insights in etiologies, clinical subtypes, and diagnostics. Front Neurol. 2016;7:26.

44. Hall CD, Herdman SJ, Whitney SL, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an evidence-based clinical practice guideline. J Neurol Phys Ther. 2016;40(2):124-155.

45. Strupp M, Lopez-Escamez JA, Kim JS, et al. Vestibular paroxysmia: diagnostic criteria. J Vestib Res. 2016;26(5-6):409-415.

46. Brandt T, Strupp M, Dieterich M. Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol. 2016;263(Suppl 1):S90-S96.

47. Strupp M, von Stuckrad-Barre S, Brandt T, Tonn JC. Teaching neuroimages: compression of the eighth cranial nerve causes vestibular paroxysmia. Neurology. 2013;80(7):e77.

48. Antunes MB. CNS Causes of Vertigo. Available at https://emedicine.medscape.com/article/884048-overview. Last accessed September 12, 2018.

49. Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. 2016;263(Suppl 1):S82-S89.

50. Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379-394.

51. Yuan Q, Yu L, Shi D, Ke X, Zhang H. Anxiety and depression among patients with different types of vestibular peripheral vertigo. Medicine (Baltimore). 2015;94(5):e453.

52. Lee H. Isolated vascular vertigo. J Stroke. 2014;16(3):124-130.

53. Caplan LR. Posterior Circulation Cerebrovascular Syndromes. Available at https://www.uptodate.com/contents/posterior-circulation-cerebrovascular-syndromes. Last accessed September 12, 2018.

54. Lang ES. Vertebrobasilar Atherothrombotic Disease. Available at https://emedicine.medscape.com/article/794678-overview. Last accessed September 12, 2018.

55. Pirau L. Vertebrobasilar Insufficiency. Available at http://knowledge.statpearls.com/chapter/0/31123. Last accessed September 12, 2018.

56. Lee H, Sohn SI, Cho YW, et al. Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns. Neurology. 2006;67(7):1178-1183.

57. Lee SU, Park SH, Park JJ, et al. Dorsal medullary infarction: a distinct syndrome of isolated central vestibulopathy. Stroke. 2015;46(11):3081-3087.

58. Zhou G, Gopen Q, Poe DS. Clinical and diagnostic characterization of canal dehiscence syndrome: a great otologic mimicker.Otol Neurotol. 2007;28(7):920-926.

59. Bertholon P, Karkas A. Otologic disorders causing dizziness, including surgery for vestibular disorders. Handb Clin Neurol. 2016;137:279-293.

60. Foris LA. Central Vertigo. Available at http://knowledge.statpearls.com/chapter/0/19151. Last accessed September 12, 2018.

61. Strupp M, Kremmyda O, Brandt T. Pharmacotherapy of vestibular disorders and nystagmus. Semin Neurol. 2013;33(3):286-296.

62. Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191-208.

63. Lee JO, Lee ES, Kim JS, et al. Altered brain function in persistent postural perceptual dizziness: a study on resting state functional connectivity. Hum Brain Mapp. 2018;39(8):3340-3353.

64. Wada M, Takeshima T, Nakamura Y, et al. Association between smoking and the peripheral vestibular disorder: a retrospective cohort study. Scientific Reports. 2017;7:16889.

65. Wei W, Sayyid ZN, Ma X, Wang T, Dong Y. Presence of anxiety and depression symptoms affects the first time treatment efficacy and recurrence of benign paroxysmal positional vertigo. Front Neurology. 2018;9:178.

66. Simon NM, Pollack MH, Tuby KS, Stern TA. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Ann Clin Psychiatry. 1998;10(2):75-80.

67. Balaban CD, Jacob RG. Background and history of the interface between anxiety and vertigo. J Anxiety Disord. 2001;15(1-2):27-51.

68. Balaban CD, Thayer JF. Neurological bases for balance-anxiety links. J Anxiety Disord. 2001;15(1-2):53-79.

69. Bigelow RT, Agrawal Y. Vestibular involvement in cognition: visuospatial ability, attention, executive function, and memory.J Vestib Res. 2015;25(2):73-89.

70. Coelho CM, Silva J, Pereira AF, et al. Visual-vestibular and postural analysis of motion sickness, panic, and acrophobia. Acta Neuropsychologica. 2017;15(1):21-33.

71. Staab JP. Functional and psychiatric vestibular disorders. Handb Clin Neurol. 2016;137:341-351.

72. Dieterich M, Staab JP, Brandt T. Functional (psychogenic) dizziness. Handb Clin Neurol. 2016;139:447-468.

73. Jacob RG, Redfern MS, Furman JM. Space and motion discomfort and abnormal balance control in patients with anxiety disorders. J Neurol Neurosurg Psychiatry. 2009;80(1):74-78.

74. Staab JP, Rohe DE, Eggers SD, Shepard NT. Anxious, introverted personality traits in patients with chronic subjective dizziness.J Psychosom Res. 2014;76(1):80-83.

75. Brandt T, Grill E, Strupp M, Huppert D. Susceptibility to fear of heights in bilateral vestibulopathy and other disorders of vertigo and balance. Front Neurol. 2018;9:406.

76. Furman JM, Jacob RG. A clinical taxonomy of dizziness and anxiety in the otoneurological setting. J Anxiety Disord. 2001;15(1-2):9-26.

77. Viaud-Delmon I, Venault P, Chapouthier G. Behavioral models for anxiety and multisensory integration in animals and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(6):1391-1399.

78. Medendorp WP, Alberts BBGT, Verhagen WIM, Koppen M, Selen LPJ. Psychophysical evaluation of sensory reweighting in bilateral vestibulopathy. Front Neurol. 2018;9:377.

79. Maire R, Mallinson A, Ceyte H, et al. Discussion about visual dependence in balance control: European Society for Clinical Evaluation of Balance Disorders. J Int Adv Otol. 2017;13(3):404-406.

80. Spiegel D. Depersonalization/Derealization Disorder. Available at https://www.merckmanuals.com/professional/psychiatric-disorders/dissociative-disorders/depersonalization-derealization-disorder. Last accessed September 12, 2018.

81. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.

82. Spiegel D, Loewenstein RJ, Lewis-Fernandez R, et al. Dissociative disorders in DSM-5. Depress Anxiety. 2011;28(9):824-852.

83. Michal M, Adler J, Wiltink J, et al. A case series of 223 patients with depersonalization-derealization syndrome. BMC Psychiatry. 2016;16:203.

84. Jáuregui RK. Vestibular function and depersonalization/derealization symptoms. Multisens Res. 2015;28(5-6):637-651.

85. Schulz A, Köster S, Beutel ME, et al. Altered patterns of heartbeat-evoked potentials in depersonalization/derealization disorder: neurophysiological evidence for impaired cortical representation of bodily signals. Psychosom Med. 2015;77(5):506-516.

86. Aranda-Moreno C, Jáuregui-Renaud K. Derealization during utricular stimulation. J Vestib Res. 2016;26(5-6):425-431.

87. Kolev OI, Georgieva-Zhostova SO, Berthoz A. Anxiety changes depersonalization and derealization symptoms in vestibular patients. Behavioural Neurology. 2014;847054.

88. Lopez C, Elzière M. Out-of-body experience in vestibular disorders: a prospective study of 210 patients with dizziness. Cortex. 2018;104:193-206.

89. Smith PF. The vestibular system and cognition. Curr Opin Neurol. 2017;30(1):84-89.

90. Bramley H, Hong J, Zacko C, Royer C, Silvis M. Mild traumatic brain injury and post-concussion syndrome: treatment and related sequela for persistent symptomatic disease. Sports Meds Arthrosc. 2016;24(3):123-129.

91. Mullally WJ. Concussion. Am J Med. 2017;130(8):885-892.

92. Fife TD, Kalra D. Persistent vertigo and dizziness after mild traumatic brain injury. Ann Acad NY Sci. 2015;1343:97-105.

93. Arshad Q, Roberts RE, Ahmad H, et al. Patients with chronic dizziness following traumatic head injury typically have multiple diagnoses involving combined peripheral and central vestibular dysfunction. Clin Neurol Neurosurg. 2017;155:17-19.

94. Reiley AS, Vickory FM, Funderburg SE, Cesario RA, Clendaniel RA. How to diagnose cervicogenic dizziness. Arch Physiother. 2017;7:12.

95. Chimirri S, Aiello R, Mazzitello C, et al. Vertigo/dizziness as a drugs' adverse reaction. J Pharmacol Pharmacother. 2013;4(Suppl 1):S104-S109.

96. Hamed SA. The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opin Drug Saf. 2017;16(11):1281-1294.

97. Mudd PA. Ototoxicity. Available at https://emedicine.medscape.com/article/857679-overview. Last accessed September 12, 2018.

98. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13(1):119-126.

99. Gürkov R. Amiodarone: a newly discovered association with bilateral vestibulopathy. Front Neurol. 2018;9:119.

100. Lai P, Coulson C, Pothier DD, Rutka J. Chlorhexidine ototoxicity in ear surgery, part 1: review of the literature. J Otolaryngol Head Neck Surg. 2011;40(6):437-440.

101. Gold DR. Dizziness and Vertigo Update. Available at http://upandrunningnetworks.com/files/C137_2.pdf. Last accessed September 12, 2018.

102. Strupp ML. How to take the patient history. Presented at: The 3rd Congress of the European Academy of Neurology; Amsterdam, The Netherlands: June 24–27, 2017.

103. Bardorf CM. Acquired Nystagmus. Available at https://emedicine.medscape.com/article/1199177-overview. Last accessed September 12, 2018.

104. Nelson JA, Viire E. The clinical differentiation of cerebellar infarction from common vertigo syndromes. West J Emerg Med. 2009;10(4):273-277.

105. Saber TAS, Kattah JC, Mantokoudis G, et al. Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms. Neurology. 2014;83(2):169-173.

106. National Institutes of Health. A classification and outline of cerebrovascular diseases. II. Stroke. 1975;6(5):564-616.

107. Paul NL, Simoni M, Rothwell PM, Oxford Vascular Study. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12(1):65-71.

108. Calic Z, Cappelen-Smith C, Anderson CS, Xuan W, Cordato DJ. Cerebellar infarction and factors associated with delayed presentation and misdiagnosis. Cerebrovasc Dis. 2016;42(5-6):476-484.

109. Arch AE, Weisman DC, Coca S, Nystrom KV, Wira CR 3rd, Schindler JL. Missed ischemic stroke diagnosis in the emergency department by emergency medicine and neurology services. Stroke. 2016;47(3):668-673.

110. Richoz B, Hugli O, Dami F, Carron PN, Faouzi M, Michel P. Acute stroke chameleons in a university hospital: risk factors, circumstances, and outcomes. Neurology. 2015;85(6):505-511.

111. Cutfield NJ, Seemungal BM, Millington H, Bronstein AM. Diagnosis of acute vertigo in the emergency department. Emerg Med J. 2011;28(6):538-539.

112. Jacob RG, Furman JM, Durrant JD, Turner SM. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry. 1996;153(4):503-512.

113. Soto-Varela A, Rossi-Izquierdo M, Sanchez-Sellero I, Santos-Perez S. Revised criteria for suspicion of non-benign positional vertigo. QJM. 2013;106(4):317-321.

114. Lee SH, Kim JS. Benign paroxysmal positional vertigo. J Clin Neurol. 2010;6(2):51-63.

115. Katon WJ. Clinical practice: panic disorder. N Engl J Med. 2006;354(22):2360-2367.

116. Shah KH, Kleckner K, Edlow JA. Short-term prognosis of stroke among patients diagnosed in the emergency department with a transient ischemic attack. Ann Emerg Med. 2008;51(3):316-323.

117. Blum CA, Kasner SE. Transient ischemic attacks presenting with dizziness or vertigo. Neurol Clin. 2015;33(3):629-642.

118. Spiegel R, Kirsch M, Rosin C, et al. Dizziness in the emergency department: an update on diagnosis. Swiss Med Wkly. 2017;147:w14565.

119. Spiegel R, Rust H, Baumann T, et al. Treatment of dizziness: an interdisciplinary update. Swiss Med Wkly. 2017;147:w14566.

120. Popkirov S, Staab JP, Stone J. Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol. 2018;18(1):5-13.

121. Kalla R, Teufel J, Feil K, Muth C, Strupp M. Update on the pharmacotherapy of cerebellar and central vestibular disorders.J Neurol. 2016;263(Suppl 1):S24-S29.

122. Bracher ES, Almeida CI, Almeida RR, Duprat AC, Bracher CB. A combined approach for the treatment of cervical vertigo.J Manipulative Physiol Ther. 2000;23(2):96-100.

123. Furman JM, Barton JJS. Evaluation of the Patient with Vertigo. Available at https://www.uptodate.com/contents/evaluation-of-the-patient-with-vertigo. Last accessed September 12, 2018.

124. Flake ZA, Linn BS, Hornecker JR. Practical selection of antiemetics in the ambulatory setting. Am Fam Physician. 2015;91(5):293-296.

125. Wipperman J. Dizziness and vertigo. Prim Care. 2014;41(1):115-131.

126. Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM. Medication-induced tardive dyskinesia: a review and update. Ochsner J. 2017;17(2):162-174.

127. Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Ménière disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:h6816.

128. Giommetti G, Lapenna R, Panichi R, et al. Residual dizziness after successful repositioning maneuver for idiopathic benign paroxysmal positional vertigo: a review. Audiol Res. 2017;7(1):178.

129. Parfenov VA, Golyk VA, Matsnev EI, et al. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: the VIRTUOSO study. PLoS One. 2017;12(3):e0174114.

130. Perna G, Caldirola D. Management of treatment-resistant panic disorder. Curr Treat Options Psych. 2017;4(4):371-386.

131. Berul CI. Acquired Long QT Syndrome: Definitions, Causes, and Pathophysiology. Available at https://www.uptodate.com/contents/acquired-long-qt-syndrome-definitions-causes-and-pathophysiology. Last accessed September 12, 2018.

132. Furman JM, Barton JJS. Treatment of Vertigo. Available at https://www.uptodate.com/contents/treatment-of-vertigo. Last accessed September 12, 2018.

133. Farrell L. Peripheral versus Central Vestibular Disorders. Available at http://www.neuropt.org/docs/vsig-physician-fact-sheets/peripheral-vs-central-vestibular-disorders.pdf?sfvrsn=e8c34543_2. Last accessed September 12, 2018.

134. Helmchen C, Klinkenstein JC, Krüger A, Gliemroth J, Mohr C, Sander T. Structural brain changes following peripheral vestibulo-cochlear lesion may indicate multisensory compensation. J Neurol Neurosurg Psychiatry. 2011;82(3):309-316.

135. Zingler VC, Weintz E, Jahn K, et al. Follow-up of vestibular function in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry. 2008;79(3):284-288.

136. Cousins S, Cutfield NJ, Kaski D, et al. Visual dependency and dizziness after vestibular neuritis. PLoS One. 2014;9(9):e105426.

137. Cousins S, Kaski D, Cutfield N, et al. Predictors of clinical recovery from vestibular neuritis: a prospective study. Ann Clin Translational Neurol. 2017;4(5):340-346.

138. Furman JM. Vestibular Neuritis and Labyrinthitis. Available at https://www.uptodate.com/contents/vestibular-neuritis-and-labyrinthitis. Last accessed September 12, 2018.

139. Godemann F, Schuller J, Uhlemann H, et al. Psychodynamic vulnerability factors in the development of panic disorders: a prospective trial in patients after vestibular neuritis. Psychopathology. 2009;42(2):99-107.

140. Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2014;12:CD003162.

141. Gufoni M, Mastrosimone L, Di Nasso F. Repositioning maneuver in benign paroxysmal vertigo of horizontal semicircular canal. Acta Otorhinolaryngol Ital. 1998;18(6):363-367.

142. Anagnostou E, Kouzi I, Spengos K. Diagnosis and treatment of anterior-canal benign paroxysmal positional vertigo: a systematic review. J Clin Neurol. 2015;11(3):262-267.

143. Kahraman SS, Arli C, Copoglu US, Kokacya MH, Colak S. The evaluation of anxiety and panic agoraphobia scores in patients with benign paroxysmal positional vertigo on initial presentation and at the follow-up visit. Acta Otolaryngol. 2017;137(5):485-489.

144. Guneri EA, Kustutan O. The effects of betahistine in addition to Epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2012;146(1):104-108.

145. Chen CC, Cho HS, Lee HH, Hu CJ. Efficacy of repositioning therapy in patients with benign paroxysmal positional vertigo and preexisting central neurologic disorders. Front Neurol. 2018;9:486.

146. Jung HJ, Koo JW, Kim CS, Kim JS, Song JJ. Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo. Acta Otolaryngol. 2012;132(3):277-284.

147. Volkenstein S, Dazert S. Recent surgical options for vestibular vertigo. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017;16:1.

148. Krog NH, Engdahl B, Tambs K. The association between tinnitus and mental health in a general population sample: results from the HUNT Study. J Psychoso Res. 2010;69(3):289-298.

149. Nauta JJ. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Eur Arch Otorhinolaryngol. 2014;271(5):887-897.

150. Moskowitz HS, Dinces EA. Meniere Disease. Available at https://www.uptodate.com/contents/meniere-disease. Last accessed September 12, 2018.

151. Møller MN, Kirkeby S, Vikeså J, Nielsen FC, Caye-Thomasen P. Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Ménière's disease. Eur Arch Otorhinolaryngol. 2016;273(7):1705-1710.

152. Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Ménière's disease: a case series. Eur Arch Otorhinolaryngol. 2011;268(8):1237-1240.

153. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005;10(19):1313-1321.

154. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope. 2004;114(12):2085-2091.

155. Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intratympanic treatment of intractable unilateral Ménière disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146(3):430-437.

156. Iliades C. Carving Out an Identity for Vestibular Migraine. Available at http://www.neurologyadvisor.com/migraine-and-headache/vestibular-migraine-diagnosis-and-treatment/article/394575. Last accessed September 12, 2018.

157. Robertson CE. Vestibular Migraine. Available at https://www.uptodate.com/contents/vestibular-migraine. Last accessed September 12, 2018.

158. Obermann M, Strupp M. Current treatment options in vestibular migraine. Front Neurol. 2014;5:257.

159. Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord. 2011;4(3):183-191.

160. Lempert T. Vestibular migraine. Semin Neurol. 2013;33(3):212-218.

161. Taghdiri F, Togha M, Razeghi Jahromi S, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. SpringerPlus. 2014;3:231.

162. Kutay Ö, Akdal G, Keskinoğlu P, Balcı BD, Alkın T. Vestibular migraine patients are more anxious than migraine patients without vestibular symptoms. J Neurol. 2017;264(Suppl 1):37-41.

163. Liu F, Ma T, Che X, Wang Q, Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol. 2017;8:524.

164. Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931-2936.

165. Porciuncula F, Johnson CC, Glickman LB. The effect of vestibular rehabilitation on adults with bilateral vestibular hypofunction: a systematic review. J Vestib Res. 2012;22(5-6):283-298.

166. Dai M, Cohen, B, Smouha E, Cho C. Readaptation of the vestibulo-ocular reflex relieves the mal de debarquement syndrome.Front Neurol. 2014;5:124.

167. Zesiewicz TA, Wilmot G, Kuo SH, et al. Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(10):464-471.

168. Austin N, Devine A, Dick I, Prince R, Bruce D. Fear of falling in older women: a longitudinal study of incidence, persistence, and predictors. J Am Geriatr Soc. 2007;55(10):1598-1603.

169. Deshpande N, Metter EJ, Lauretani F, Bandinelli S, Guralnik J, Ferrucci L. Activity restriction induced by fear of falling and objective and subjective measures of physical function: a prospective cohort study. J Am Geriatr Soc. 2008;56(4):615-620.

170. Visschedijk J, Achterberg W, Van Balen R, Hertogh C. Fear of falling after hip fracture: a systematic review of measurement instruments, prevalence, interventions, and related factors. J Am Geriatr Soc. 2010;58(9):1739-1748.

171. Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693-698.

172. Jumani K, Powell J. Benign paroxysmal positional vertigo: management and its impact on falls. Ann Otol Rhinol Laryngol. 2017;126(8):602-605.

173. Branch WT, Barton JJS. Approach to the Patient with Dizziness. Available at https://www.uptodate.com/contents/approach-to-the-patient-with-dizziness. Last accessed September 12, 2018.

174. Kiel DP. Falls in Older Persons: Risk Factors and Patient Evaluation. Available at https://www.uptodate.com/contents/falls-in-older-persons-risk-factors-and-patient-evaluation. Last accessed September 12, 2018.

175. Maarsingh OR, Dros J, Schellevis FG, et al. Causes of persistent dizziness in elderly patients in primary care. Ann Fam Med. 2010;8(3):196-205.

176. Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing. 2006;35(suppl 2):ii37-ii41.

177. D'Silva LJ, Staecker H, Lin J, et al. Retrospective data suggests that the higher prevalence of benign paroxysmal positional vertigo in individuals with type 2 diabetes is mediated by hypertension. J Vestib Res. 2016;25(5-6):233-239.

178. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin. 2005;23(3):831-853.

Evidence-Based Practice Recommendations Citations

1. Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Menière's disease. J Vestib Res. 2015;25(1):1-7. Available at http://www.jvr-web.org/images/55807-Lopez-Escamez.pdf. Last accessed September 18, 2018.

2. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017;156(3 suppl):S1-S47. Available at http://journals.sagepub.com/doi/pdf/10.1177/0194599816689667. Last accessed September 18, 2018.

3. Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): sonsensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191-208. Available at https://content.iospress.com/articles/journal-of-vestibular-research/ves622. Last accessed September 18, 2018.

4. Hall CD, Herdman SJ, Whitney SL, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an evidence-based clinical practice guideline: from the American Physical Therapy Association Neurology Section. J Neurol Phys Ther. 2016;40(2):124-155. Summary available at https://www.asha.org/articlesummary.aspx?id=8589969232. Last accessed September 18, 2018.


Copyright © 2018 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.